Dr Rob van Montfort’s group uses screening techniques to narrow down the number of potential molecules to take forward into drug development.
Dr Rob van Montfort uses protein crystallography and a range of biochemical and biophysical approaches to investigate ligand-binding to new cancer drug targets. He has a joint appointment between the Divisions of Cancer Therapeutics and Structural Biology at the Centre for Cancer Drug Discovery.